Cover Image
市場調查報告書

Oncolys BioPharma Inc. - 產品平台分析

Oncolys BioPharma Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251698
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Oncolys BioPharma Inc. - 產品平台分析 Oncolys BioPharma Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 29 Pages
簡介

Oncolys BioPharma Inc.是總公司設立於日本的生物科技企業, 正在開發以癌症及感染疾病為標的治療藥,從事利用病毒的癌症治療藥,針對感染疾病的治療藥,分子標的抗癌藥,癌症診斷藥等之研究與開發。

本報告提供Oncolys BioPharma Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

目錄

Oncolys BioPharma Inc. 的基本資料

  • Oncolys BioPharma Inc. 概要
  • 主要資訊
  • 企業資料

Oncolys BioPharma Inc. :R&D概要

  • 主要的治療範圍

Oncolys BioPharma Inc. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Oncolys BioPharma Inc. :開發中產品概況

  • 臨床階段的開發中產品
    • 第Ⅱ階段的產品/聯合治療模式
    • 第Ⅰ階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Oncolys BioPharma Inc. :藥物簡介

  • censavudine
  • OBP-301
  • OBP-801
  • OBP-702
  • OBPAI-001
  • OBPAI-002

Oncolys BioPharma Inc. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Oncolys BioPharma Inc. :最新的開發平台資訊

Oncolys BioPharma Inc. :開發被休止的計劃

Oncolys BioPharma Inc. :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07384CDB

Summary

Global Markets Direct's, 'Oncolys BioPharma Inc. - Product Pipeline Review - 2015', provides an overview of the Oncolys BioPharma Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Oncolys BioPharma Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Oncolys BioPharma Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Oncolys BioPharma Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Oncolys BioPharma Inc.'s pipeline products

Reasons to buy

  • Evaluate Oncolys BioPharma Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Oncolys BioPharma Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Oncolys BioPharma Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Oncolys BioPharma Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Oncolys BioPharma Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Oncolys BioPharma Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Oncolys BioPharma Inc. Snapshot
    • Oncolys BioPharma Inc. Overview
    • Key Information
    • Key Facts
  • Oncolys BioPharma Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Oncolys BioPharma Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Oncolys BioPharma Inc. - Pipeline Products Glance
    • Oncolys BioPharma Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Oncolys BioPharma Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Oncolys BioPharma Inc. - Drug Profiles
    • censavudine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OBP-301
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OBP-801
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OBP-702
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OBPAI-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OBPAI-002
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Oncolys BioPharma Inc. - Pipeline Analysis
    • Oncolys BioPharma Inc. - Pipeline Products by Target
    • Oncolys BioPharma Inc. - Pipeline Products by Route of Administration
    • Oncolys BioPharma Inc. - Pipeline Products by Molecule Type
    • Oncolys BioPharma Inc. - Pipeline Products by Mechanism of Action
  • Oncolys BioPharma Inc. - Recent Pipeline Updates
  • Oncolys BioPharma Inc. - Dormant Projects
  • Oncolys BioPharma Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Oncolys BioPharma Inc., Key Information
  • Oncolys BioPharma Inc., Key Facts
  • Oncolys BioPharma Inc. - Pipeline by Indication, 2015
  • Oncolys BioPharma Inc. - Pipeline by Stage of Development, 2015
  • Oncolys BioPharma Inc. - Monotherapy Products in Pipeline, 2015
  • Oncolys BioPharma Inc. - Phase II, 2015
  • Oncolys BioPharma Inc. - Phase I, 2015
  • Oncolys BioPharma Inc. - Preclinical, 2015
  • Oncolys BioPharma Inc. - Discovery, 2015
  • Oncolys BioPharma Inc. - Pipeline by Target, 2015
  • Oncolys BioPharma Inc. - Pipeline by Route of Administration, 2015
  • Oncolys BioPharma Inc. - Pipeline by Molecule Type, 2015
  • Oncolys BioPharma Inc. - Pipeline Products by Mechanism of Action, 2015
  • Oncolys BioPharma Inc. - Recent Pipeline Updates, 2015
  • Oncolys BioPharma Inc. - Dormant Developmental Projects,2015
  • Oncolys BioPharma Inc., Other Locations

List of Figures

  • Oncolys BioPharma Inc. - Pipeline by Top 10 Indication, 2015
  • Oncolys BioPharma Inc. - Pipeline by Stage of Development, 2015
  • Oncolys BioPharma Inc. - Monotherapy Products in Pipeline, 2015
  • Oncolys BioPharma Inc. - Pipeline by Top 10 Target, 2015
  • Oncolys BioPharma Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Oncolys BioPharma Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Oncolys BioPharma Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top